Connection

Adriana Olar to Humans

Back to Details
This is a "connection" page, showing publications Adriana Olar has written about Humans.
Adriana Olar
Connection Strength
0.502
Humans
  1. Genetic and histologic spatiotemporal evolution of recurrent, multifocal, multicentric and metastatic glioblastoma. Acta Neuropathol Commun. 2020 02 03; 8(1):10.
    View in: PubMed
    Score: 0.027
  2. Current clinical management of patients with glioblastoma. Cancer Rep (Hoboken). 2019 12; 2(6):e1216.
    View in: PubMed
    Score: 0.026
  3. ATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic features. Clin Neuropathol. 2019 Mar/Apr; 38(2):59-73.
    View in: PubMed
    Score: 0.025
  4. Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls. Acta Neuropathol Commun. 2018 10 19; 6(1):107.
    View in: PubMed
    Score: 0.025
  5. Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma. Acta Neuropathol. 2017 03; 133(3):431-444.
    View in: PubMed
    Score: 0.022
  6. Central nervous system involvement by myeloid sarcoma: a report of 12 cases and review of the literature. Clin Neuropathol. 2016 Sep-Oct; 35(5):314-25.
    View in: PubMed
    Score: 0.021
  7. Phosphohistone H3: implications for clinical practice and risk assessment in meningioma. Neuro Oncol. 2015 May; 17(5):631-3.
    View in: PubMed
    Score: 0.019
  8. Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification. Semin Radiat Oncol. 2015 Jul; 25(3):155-63.
    View in: PubMed
    Score: 0.019
  9. IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathol. 2015 Apr; 129(4):585-96.
    View in: PubMed
    Score: 0.019
  10. Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma. Brain Pathol. 2015 May; 25(3):266-75.
    View in: PubMed
    Score: 0.019
  11. Biologic correlates and significance of axonogenesis in prostate cancer. Hum Pathol. 2014 Jul; 45(7):1358-64.
    View in: PubMed
    Score: 0.018
  12. Biological correlates of prostate cancer perineural invasion diameter. Hum Pathol. 2014 Jul; 45(7):1365-9.
    View in: PubMed
    Score: 0.018
  13. Using the molecular classification of glioblastoma to inform personalized treatment. J Pathol. 2014 Jan; 232(2):165-77.
    View in: PubMed
    Score: 0.018
  14. Molecular classification of diffuse gliomas. Oncology (Williston Park). 2013 Jun; 27(6):514, 518, 520.
    View in: PubMed
    Score: 0.017
  15. Biomarkers classification and therapeutic decision-making for malignant gliomas. Curr Treat Options Oncol. 2012 Dec; 13(4):417-36.
    View in: PubMed
    Score: 0.017
  16. Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults. Ann Diagn Pathol. 2012 Jun; 16(3):161-70.
    View in: PubMed
    Score: 0.015
  17. Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour types. Neuropathol Appl Neurobiol. 2022 12; 48(7):e12847.
    View in: PubMed
    Score: 0.008
  18. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline. J Clin Oncol. 2022 02 01; 40(4):403-426.
    View in: PubMed
    Score: 0.008
  19. Seizures in Patients With Metastatic Brain Tumors: Prevalence, Clinical Characteristics, and Features on EEG. J Clin Neurophysiol. 2021 Mar 01; 38(2):143-148.
    View in: PubMed
    Score: 0.007
  20. Rathke's Cleft Cyst Apoplexy in Two Teenage Sisters. Pediatr Neurosurg. 2019; 54(6):428-435.
    View in: PubMed
    Score: 0.007
  21. Clinical characteristics, EEG findings and implications of status epilepticus in patients with brain metastases. J Neurol Sci. 2019 Dec 15; 407:116538.
    View in: PubMed
    Score: 0.007
  22. Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course. Acta Neuropathol. 2020 01; 139(1):193-209.
    View in: PubMed
    Score: 0.007
  23. Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors. Neuro Oncol. 2019 09 06; 21(9):1164-1174.
    View in: PubMed
    Score: 0.007
  24. Seizures in patents with primary central nervous system lymphoma: Prevalence and associated features. J Neurol Sci. 2019 May 15; 400:34-38.
    View in: PubMed
    Score: 0.006
  25. DNA methylation-based reclassification of olfactory neuroblastoma. Acta Neuropathol. 2018 08; 136(2):255-271.
    View in: PubMed
    Score: 0.006
  26. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathol. 2018 08; 136(2):273-291.
    View in: PubMed
    Score: 0.006
  27. DNA methylation-based classification of central nervous system tumours. Nature. 2018 03 22; 555(7697):469-474.
    View in: PubMed
    Score: 0.006
  28. Ependymomas arising outside of the central nervous system: A case series and literature review. J Clin Neurosci. 2018 Jan; 47:202-207.
    View in: PubMed
    Score: 0.006
  29. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell. 2017 07 10; 32(1):42-56.e6.
    View in: PubMed
    Score: 0.006
  30. Sarcoma Brain Metastases: 28?Years of Experience at a Single Institution. Ann Surg Oncol. 2016 12; 23(Suppl 5):962-967.
    View in: PubMed
    Score: 0.005
  31. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol. 2016 06; 40(6):847-56.
    View in: PubMed
    Score: 0.005
  32. Next-generation sequencing of central nervous systems tumors: the future of personalized patient management. Neuro Oncol. 2016 Mar; 18(3):308-10.
    View in: PubMed
    Score: 0.005
  33. Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroups. Neuro Oncol. 2016 06; 18(6):790-6.
    View in: PubMed
    Score: 0.005
  34. Primary intracranial soft tissue sarcomas in children, adolescents, and young adults: single institution experience and review of the literature. J Neurooncol. 2016 Mar; 127(1):155-63.
    View in: PubMed
    Score: 0.005
  35. TERT Promoter Mutations and Risk of Recurrence in Meningioma. J Natl Cancer Inst. 2016 May; 108(5).
    View in: PubMed
    Score: 0.005
  36. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol. 2015 Nov; 125(2):401-10.
    View in: PubMed
    Score: 0.005
  37. IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO. Acta Neuropathol. 2015 Jun; 129(6):867-73.
    View in: PubMed
    Score: 0.005
  38. Corticosteroid sensitivity in gliomatosis cerebri delays diagnosis. Pract Neurol. 2015 Aug; 15(4):309-11.
    View in: PubMed
    Score: 0.005
  39. C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma. Brain Tumor Pathol. 2015 Apr; 32(2):105-11.
    View in: PubMed
    Score: 0.005
  40. Supratentorial extraventricular anaplastic ependymoma with extracranial metastasis. J Clin Neurosci. 2015 Mar; 22(3):605-7.
    View in: PubMed
    Score: 0.005
  41. Brain metastasis of crystal-deficient, CD68-positive alveolar soft part sarcoma: ultrastructural features and differential diagnosis. Ultrastruct Pathol. 2015 Feb; 39(1):69-77.
    View in: PubMed
    Score: 0.005
  42. Lambrolizumab induced central nervous system (CNS) toxicity. J Neurol Sci. 2014 Sep 15; 344(1-2):229-31.
    View in: PubMed
    Score: 0.005
  43. Clinical and prognostic features of adult patients with gangliogliomas. Neuro Oncol. 2014 Mar; 16(3):409-13.
    View in: PubMed
    Score: 0.004
  44. A case of severe chronic progressive axonal polyradiculoneuropathy temporally associated with anti-CV2/CRMP5 antibodies. J Clin Neuromuscul Dis. 2013 Sep; 15(1):13-8.
    View in: PubMed
    Score: 0.004
  45. Mesenchymal differentiation mediated by NF-?B promotes radiation resistance in glioblastoma. Cancer Cell. 2013 Sep 09; 24(3):331-46.
    View in: PubMed
    Score: 0.004
  46. Olfactory colloid cyst: case report and review of extraventricular colloid cyst literature. World Neurosurg. 2014 Jan; 81(1):202.e19-22.
    View in: PubMed
    Score: 0.004
  47. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma. Ann Diagn Pathol. 2012 Aug; 16(4):255-9.
    View in: PubMed
    Score: 0.004
  48. Myxoid liposarcoma: a case report of a sentinel metastasis to the parotid gland with molecular confirmation. Diagn Cytopathol. 2011 Oct; 39(10):780-3.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.